11 min listen
ACCEL Lite: Should You “Aspirin” in Older Adults With Subclinical Atherosclerosis?
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: Should You “Aspirin” in Older Adults With Subclinical Atherosclerosis?
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
14 minutes
Released:
Jul 6, 2021
Format:
Podcast episode
Description
In this interview, Kim Williams MD, MACC; John William “Bill” McEvoy, MB, BCh, MHS; and Michelle Kelsey, MD, discuss whether to use aspirin for primary prevention in adults >70 years old with subclinical atherosclerosis. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.
Released:
Jul 6, 2021
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: STRENGTH Trial: High-Dose Omega-3 Fatty Acids vs. Corn Oil: The benefits and risks of fish oil derivatives remain controversial. STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) showed no benefits from administration... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research